Regeneron Pharmaceuticals, Inc. (REGN) balance sheet
NASDAQ · Healthcare · Biotechnology · 15,410 employees · CEO Leonard S. Schleifer
- Price
- $927.89 +13.33%
- Market cap
- $95.5B
- Enterprise value
- $94.6B
- Last report
- Q3 '26 filed 2026-10-30
- Next report
- 2027-01-28 EPS est. $24.25
At the end of Q3 '26 Regeneron Pharmaceuticals, Inc. (REGN) held $9.3B in cash and short-term investments against $2.71B of debt incl. leases. Total assets $44.4B, total liabilities $10.9B, shareholders' equity $33.5B.
Balance sheet
| Balance sheet | Trend | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & equivalents | $2.73B | $2.6B | $1.92B | $2.01B | $2.49B | $3.09B | $2B | $2.51B | $3.12B | $2.96B | $2.46B | $3.66B | |
| Short-term investments | $8.11B | $7.92B | $7.89B | $7.78B | $6.52B | $5.26B | $5.47B | $5.94B | $5.49B | $5.79B | $5.54B | $5.64B | |
| Receivables | $5.67B | $5.22B | $5.72B | $6.11B | $6.21B | $5.56B | $5.61B | $5.69B | $5.74B | $5.73B | $6.57B | $7.58B | |
| Inventory | $2.58B | $2.71B | $2.87B | $3.02B | $3.09B | $3.19B | $3.21B | $3.25B | $3.2B | $3.1B | $3.08B | $2.89B | |
| Other current assets | $387M | $415M | $682M | $412M | $349M | $469M | $574M | $596M | $475M | $0 | $0 | $0 | |
| Current assets | $19.5B | $18.9B | $19.1B | $19.3B | $18.7B | $17.6B | $16.9B | $18B | $18B | $18.2B | $18.4B | $20.8B | |
| Property, plant & equipment (net) | $4.15B | $4.23B | $4.31B | $4.44B | $4.6B | $4.69B | $4.84B | $5B | $5.12B | $5.27B | $5.46B | $5.73B | |
| Long-term investments | $5.4B | $6.98B | $7.72B | $8.49B | $8.9B | $9.28B | $10.1B | $10.3B | $10.3B | $9.79B | $9.83B | $9.56B | |
| Intangible assets | $1.04B | $1.06B | $1.1B | $1.12B | $1.15B | $1.17B | $1.35B | $1.38B | $1.26B | $1.29B | $1.31B | $1.32B | |
| Deferred tax assets | $2.58B | $2.76B | $2.88B | $3.02B | $3.31B | $3.44B | $3.57B | $3.85B | $4.08B | $4.19B | $4.38B | $4.54B | |
| Other non-current assets | $444M | $470M | $994M | $1.04B | $1.14B | $1.39B | $1.54B | $1.67B | $1.82B | $2.13B | $2.31B | $2.47B | |
| Non-current assets | $13.6B | $15.5B | $17B | $18.1B | $19.1B | $20B | $21.4B | $22.2B | $22.5B | $22.7B | $23.3B | $23.6B | |
| Total assets | $33.1B | $34.4B | $36.1B | $37.4B | $37.8B | $37.5B | $38.2B | $40.2B | $40.6B | $40.9B | $41.7B | $44.4B | |
| Liabilities | |||||||||||||
| Accounts payable | $607M | $671M | $562M | $497M | $790M | $706M | $724M | $904M | $939M | $1.03B | $1.16B | $1.14B | |
| Accrued expenses | $2.35B | $2.39B | $2.36B | $2.54B | $2.31B | $2.24B | $2.46B | $2.98B | $2.53B | $2.72B | $2.97B | $3.59B | |
| Taxes payable | $0 | $0 | $0 | $0 | $213M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Deferred revenue | $459M | $517M | $586M | $627M | $628M | $619M | $482M | $546M | $553M | $636M | $220M | $750M | |
| Other current liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.18B | $0 | |
| Current liabilities | $3.42B | $3.58B | $3.51B | $3.66B | $3.94B | $3.57B | $3.67B | $4.43B | $4.37B | $5.11B | $5.53B | $6.2B | |
| Long-term debt | $1.98B | $1.98B | $1.98B | $1.98B | $1.98B | $1.98B | $1.99B | $1.99B | $1.99B | $1.99B | $1.99B | $1.99B | |
| Lease obligations (non-current) | $720M | $720M | $720M | $720M | $720M | $720M | $720M | $720M | $720M | $0 | $0 | $0 | |
| Deferred revenue (non-current) | $127M | $186M | $206M | $207M | $186M | $212M | $206M | $219M | $209M | $225M | $0 | $220M | |
| Other non-current liabilities | $854M | $909M | $1.46B | $1.54B | $1.57B | $1.67B | $1.7B | $1.86B | $2.02B | $2.13B | $2.5B | $2.5B | |
| Non-current liabilities | $3.68B | $3.8B | $4.37B | $4.46B | $4.46B | $4.59B | $4.61B | $4.79B | $4.93B | $4.34B | $4.49B | $4.7B | |
| Total liabilities | $7.11B | $7.38B | $7.88B | $8.12B | $8.41B | $8.16B | $8.28B | $9.21B | $9.3B | $9.45B | $10B | $10.9B | |
| Equity | |||||||||||||
| Common stock & paid-in capital | $100K | $100K | $100K | $100K | $100K | $100K | $100K | $100K | $100K | $100K | $0 | $100K | |
| Retained earnings | $27.3B | $28B | $29.4B | $30.8B | $31.7B | $32.4B | $33.7B | $35B | $35.8B | $36.4B | $37.6B | $39.5B | |
| Accumulated other comprehensive income | -$80.9M | -$77.2M | -$69.9M | $60.2M | -$7.9M | $29.1M | $52.5M | $69M | $77.5M | $11.9M | -$35.8M | -$198M | |
| Shareholders' equity | $26B | $27B | $28.2B | $29.3B | $29.4B | $29.4B | $29.9B | $31B | $31.3B | $31.4B | $31.7B | $33.5B | |
| Debt | |||||||||||||
| Total debt (incl. leases) | $2.7B | $2.7B | $2.7B | $2.7B | $2.7B | $2.7B | $2.71B | $2.71B | $2.71B | $2.71B | $1.99B | $2.71B | |
| Net debt (debt - cash) | -$27.1M | $101M | $783M | $692M | $216M | -$385M | $709M | $199M | -$412M | -$256M | -$469M | -$952M | |
| Balance sheet | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & equivalents | $535M | $813M | $1.47B | $1.62B | $2.19B | $2.89B | $3.11B | $2.73B | $2.49B | $3.12B | |
| Short-term investments | $503M | $597M | $1.34B | $1.6B | $1.39B | $2.81B | $4.64B | $8.11B | $6.52B | $5.49B | |
| Receivables | $1.61B | $1.97B | $2.24B | $2.79B | $4.11B | $6.04B | $5.33B | $5.67B | $6.21B | $5.74B | |
| Inventory | $399M | $726M | $1.15B | $1.42B | $1.92B | $1.95B | $2.4B | $2.58B | $3.09B | $3.2B | |
| Other current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $387M | $349M | $475M | |
| Current assets | $3.91B | $5.6B | $7.96B | $7.69B | $9.78B | $14B | $15.9B | $19.5B | $18.7B | $18B | |
| Property, plant & equipment (net) | $2.08B | $2.36B | $2.58B | $2.89B | $3.22B | $3.48B | $3.76B | $4.15B | $4.6B | $5.12B | |
| Long-term investments | $864M | $1.49B | $1.76B | $3.26B | $3.14B | $6.84B | $6.59B | $5.4B | $8.9B | $10.3B | |
| Intangible assets | $0 | $0 | $0 | $0 | $0 | $6.7M | $916M | $1.04B | $1.15B | $1.26B | |
| Deferred tax assets | $825M | $506M | $829M | $824M | $859M | $877M | $1.72B | $2.58B | $3.31B | $4.08B | |
| Other non-current assets | $20.3M | $77.9M | $127M | $145M | $168M | $216M | $336M | $444M | $1.14B | $1.82B | |
| Non-current assets | $3.79B | $4.43B | $5.29B | $7.12B | $7.38B | $11.4B | $13.3B | $13.6B | $19.1B | $22.5B | |
| Total assets | $6.97B | $8.76B | $11.7B | $14.8B | $17.2B | $25.4B | $29.2B | $33.1B | $37.8B | $40.6B | |
| Liabilities | |||||||||||
| Accounts payable | $135M | $178M | $218M | $418M | $476M | $564M | $589M | $607M | $790M | $939M | |
| Accrued expenses | $508M | $637M | $751M | $1.16B | $1.61B | $1.59B | $2.07B | $2.35B | $2.31B | $2.53B | |
| Taxes payable | $236M | $227K | $20.8M | $49.4M | $19.5M | $326M | $300K | $0 | $213M | $0 | |
| Deferred revenue | $232M | $320M | $453M | $592M | $578M | $442M | $478M | $459M | $628M | $553M | |
| Other current liabilities | $1.18M | $0 | $0 | $85M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Current liabilities | $1.24B | $1.14B | $1.44B | $2.1B | $2.7B | $3.93B | $3.14B | $3.42B | $3.94B | $4.37B | |
| Long-term debt | $0 | $0 | $0 | $0 | $1.98B | $1.98B | $1.98B | $1.98B | $1.98B | $1.99B | |
| Lease obligations (non-current) | $352M | $704M | $709M | $714M | $717M | $0 | $720M | $720M | $720M | $720M | |
| Deferred revenue (non-current) | $831M | $629M | $464M | $105M | $57.8M | $73.3M | $69.8M | $127M | $186M | $209M | |
| Other non-current liabilities | $100M | $949M | $547M | $800M | $687M | $680M | $638M | $854M | $1.57B | $2.02B | |
| Non-current liabilities | $1.28B | $1.48B | $1.53B | $1.62B | $3.44B | $2.73B | $3.41B | $3.68B | $4.46B | $4.93B | |
| Total liabilities | $2.52B | $2.62B | $2.98B | $3.72B | $6.14B | $6.67B | $6.55B | $7.11B | $8.41B | $9.3B | |
| Equity | |||||||||||
| Common stock & paid-in capital | $110K | $112K | $100K | $100K | $100K | $100K | $100K | $100K | $100K | $100K | |
| Retained earnings | $1.75B | $2.95B | $5.25B | $7.38B | $10.9B | $19B | $23.3B | $27.3B | $31.7B | $35.8B | |
| Accumulated other comprehensive income | -$12.8M | $640K | -$12.3M | $21.1M | $29.3M | -$26.2M | -$239M | -$80.9M | -$7.9M | $77.5M | |
| Shareholders' equity | $4.45B | $6.14B | $8.76B | $11.1B | $11B | $18.8B | $22.7B | $26B | $29.4B | $31.3B | |
| Debt | |||||||||||
| Total debt (incl. leases) | $481M | $703M | $709M | $714M | $2.7B | $2.7B | $2.7B | $2.7B | $2.7B | $2.71B | |
| Net debt (debt - cash) | -$54.1M | -$109M | -$759M | -$904M | $502M | -$186M | -$405M | -$27.1M | $216M | -$412M | |
Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Cash, investments and debt
quarter endsThe other statements
Sources
Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
Data as of 2026-11-01